C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China flag China · Delayed Price · Currency is CNY
4.890
-0.030 (-0.61%)
Nov 17, 2026, 3:04 PM CST

SHE:000950 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
4,5086,6849,3929,1497,4225,665
Trading Asset Securities
----6.912.4
Cash & Short-Term Investments
4,5086,6849,3929,1497,4295,677
Cash Growth
-15.05%-28.83%2.65%23.15%30.86%20.98%
Accounts Receivable
40,66037,11134,42333,71929,62026,988
Other Receivables
1,5271,6511,8931,4431,3891,243
Receivables
42,18738,76236,31635,16231,00928,231
Inventory
9,91710,0419,9778,6037,8636,051
Prepaid Expenses
----19.44-
Other Current Assets
1,4721,4651,7351,6212,3881,379
Total Current Assets
58,08556,95257,42054,53448,70841,338
Property, Plant & Equipment
2,6772,6292,6242,6262,6502,557
Long-Term Investments
3,4173,3383,2683,0913,0322,958
Goodwill
1,4021,4311,4611,5011,5091,461
Other Intangible Assets
304317.63311.73320.01263.57262.32
Long-Term Accounts Receivable
-38.1785.2849.491.412.78
Long-Term Deferred Tax Assets
721.14672.82438.89328.69225.67255
Long-Term Deferred Charges
171.46179.62178.7173.63123.41105.23
Other Long-Term Assets
689.88681.11770.04798.8679.13761.64
Total Assets
67,46766,23966,63063,48157,19249,700

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
19,67520,22218,16517,43713,76112,126
Accrued Expenses
178.57792.04678.31583.19523.3492
Short-Term Debt
21,96620,26616,24316,76317,07913,806
Current Portion of Long-Term Debt
1,945605.152,3641,5403,799430.56
Current Portion of Leases
-110.3166.37170.72154.9156.81
Current Income Taxes Payable
216.19200.93111.48139.08126.97155.39
Current Unearned Revenue
956.73764.67528.08447.73716.16215.53
Other Current Liabilities
3,4633,7805,8075,7804,5154,342
Total Current Liabilities
48,40046,74144,06442,86040,67431,724
Long-Term Debt
1,8302,4265,3704,4393,1235,434
Long-Term Leases
315.13284.56259.06266.34228.74226.31
Long-Term Unearned Revenue
67.3264.4963.6268.0273.0876.25
Pension & Post-Retirement Benefits
45.6950.6454.4553.2655.3857.53
Long-Term Deferred Tax Liabilities
24.3520.9868.5454.8347.1457.64
Other Long-Term Liabilities
90.8397.18287.01274.16280.13357.31
Total Liabilities
50,77349,68550,16748,01644,48137,934

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,7131,7281,7281,7281,7431,743
Additional Paid-In Capital
2,4262,4922,4812,4942,4362,437
Retained Earnings
7,7777,5087,2257,0816,5605,720
Treasury Stock
--81.15---41.9-41.9
Comprehensive Income & Other
-110.55-110.18-107.62-86.79-45.76-36.92
Total Common Equity
11,80611,53611,32711,21610,6529,821
Minority Interest
4,8885,0185,1364,2502,0591,946
Shareholders' Equity
16,69416,55416,46315,46512,71011,767
Total Liabilities & Equity
67,46766,23966,63063,48157,19249,700

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
26,05523,69324,40323,17924,38420,054
Net Cash (Debt)
-21,547-17,009-15,012-14,030-16,955-14,377
Net Cash Growth
------
Net Cash Per Share
-12.26-9.68-8.49-8.09-9.79-8.29
Filing Date Shares Outstanding
1,7131,7131,7281,7281,7431,692
Total Common Shares Outstanding
1,7131,7131,7281,7281,7431,692
Working Capital
9,68410,21113,35611,6748,0349,613
Book Value Per Share
6.896.746.556.496.115.81
Tangible Book Value
10,1009,7879,5549,3948,8798,098
Tangible Book Value Per Share
5.905.715.535.445.094.79
Buildings
-2,2102,2012,2122,1061,773
Machinery
-1,3301,2361,128956.1736.98
Construction In Progress
-198.0767.631.76169.58474.58